Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suzann Pershing

Showing results (91-100 of 94) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 94 results.
Ophthalmology Science|June 5, 2023
Cataract Surgery in the Medicare Merit-Based Incentive Payment System: Episode-Based Cost Measure Development and EvaluationSuzann Pershing, Alexander T Sandhu, Aimée-Sandrine Uwilingiyimana, et al.
Pharmacoepidemiology and Drug Safety|November 10, 2025
Validation of the US Food and Drug Administration's COVID-19 Disease Severity Categorization for Use in Real-World DataSilvia Perez-Vilar, Wei Hua, Andrew Kwist, et al.
American Journal of Ophthalmology|May 2, 2016
Defining a Minimum Set of Standardized Patient-centered Outcome Measures for Macular DegenerationIan A Rodrigues, Sara M Sprinkhuizen, Daniel Barthelmes, et al.
Clinical & Experimental Ophthalmology|February 27, 2026
Decline of Visual Function and Risk of Legal Blindness With Age in RPGR-Associated Retinal Degeneration: A Multicenter StudyBela J Parekh, Joshua D Stein, Rebhi Abuzaitoun, et al.
Pageof 10

Showing results (91-100 of 94) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 94 results.
Ophthalmology Science|June 5, 2023
Cataract Surgery in the Medicare Merit-Based Incentive Payment System: Episode-Based Cost Measure Development and EvaluationSuzann Pershing, Alexander T Sandhu, Aimée-Sandrine Uwilingiyimana, et al.
Pharmacoepidemiology and Drug Safety|November 10, 2025
Validation of the US Food and Drug Administration's COVID-19 Disease Severity Categorization for Use in Real-World DataSilvia Perez-Vilar, Wei Hua, Andrew Kwist, et al.
American Journal of Ophthalmology|May 2, 2016
Defining a Minimum Set of Standardized Patient-centered Outcome Measures for Macular DegenerationIan A Rodrigues, Sara M Sprinkhuizen, Daniel Barthelmes, et al.
Clinical & Experimental Ophthalmology|February 27, 2026
Decline of Visual Function and Risk of Legal Blindness With Age in RPGR-Associated Retinal Degeneration: A Multicenter StudyBela J Parekh, Joshua D Stein, Rebhi Abuzaitoun, et al.
Pageof 10